These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15920339)

  • 1. Metabolic changes in pelvic lesions: findings at proton MR spectroscopic imaging.
    Hascalik S; Celik O; Sarac K; Meydanli MM; Alkan A; Mizrak B
    Gynecol Obstet Invest; 2005; 60(3):121-7. PubMed ID: 15920339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three Tesla.
    Stanwell P; Russell P; Carter J; Pather S; Heintze S; Mountford C
    Invest Radiol; 2008 Oct; 43(10):745-51. PubMed ID: 18791417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
    Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
    Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance spectroscopy features of uterine leiomyomas.
    Celik O; Sarac K; Hascalik S; Alkan A; Mizrak B; Yologlu S
    Gynecol Obstet Invest; 2004; 58(4):194-201. PubMed ID: 15286450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
    Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
    J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas.
    Demir MK; Iplikcioglu AC; Dincer A; Arslan M; Sav A
    Eur J Radiol; 2006 Oct; 60(1):48-55. PubMed ID: 16844335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR Spectroscopy for Differentiating Benign From Malignant Solid Adnexal Tumors.
    Ma FH; Qiang JW; Cai SQ; Zhao SH; Zhang GF; Rao YM
    AJR Am J Roentgenol; 2015 Jun; 204(6):W724-30. PubMed ID: 26001263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.
    Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X
    Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vivo proton magnetic resonance spectroscopy in adnexal lesions.
    Cho SW; Cho SG; Lee JH; Kim HJ; Lim MK; Kim JH; Suh CH
    Korean J Radiol; 2002; 3(2):105-12. PubMed ID: 12087200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging and spectroscopy of pilomyxoid astrocytomas: case reports and comparison with pilocytic astrocytomas.
    Morales H; Kwock L; Castillo M
    J Comput Assist Tomogr; 2007; 31(5):682-7. PubMed ID: 17895777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of musculoskeletal tumors by proton MR spectroscopy.
    Fayad LM; Barker PB; Bluemke DA
    Semin Musculoskelet Radiol; 2007 Sep; 11(3):240-5. PubMed ID: 18260034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application value of 3T 1H-magnetic resonance spectroscopy in diagnosing tumors of bone and soft tissue].
    Qi ZH; Li CF; Ma XX; Li ZF; Zhang K; Yu DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):504-10. PubMed ID: 22338133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of MRS in the differentiation of benign and malignant soft tissue and bone tumors.
    Doganay S; Altinok T; Alkan A; Kahraman B; Karakas HM
    Eur J Radiol; 2011 Aug; 79(2):e33-7. PubMed ID: 21376496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary assessment of benign maxillofacial and neck lesions with in vivo single-voxel 1H magnetic resonance spectroscopy.
    Yu Q; Yang J; Wang P; Shi H; Luo J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):264-70. PubMed ID: 17630099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
    Zacharia TT; Law M; Naidich TP; Leeds NE
    J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
    Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
    Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions.
    Möller-Hartmann W; Herminghaus S; Krings T; Marquardt G; Lanfermann H; Pilatus U; Zanella FE
    Neuroradiology; 2002 May; 44(5):371-81. PubMed ID: 12012120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.